nilotinib
Generic: nilotinib
Labeler: novadoz pharmaceuticals llcDrug Facts
Product Profile
Brand Name
nilotinib
Generic Name
nilotinib
Labeler
novadoz pharmaceuticals llc
Dosage Form
CAPSULE
Routes
Active Ingredients
nilotinib 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72205-239
Product ID
72205-239_13b46e09-62d2-4ce9-b3c0-deafcb1f1842
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA218544
Listing Expiration
2026-12-31
Marketing Start
2025-11-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72205239
Hyphenated Format
72205-239
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nilotinib (source: ndc)
Generic Name
nilotinib (source: ndc)
Application Number
ANDA218544 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 28 CAPSULE in 1 BLISTER PACK (72205-239-63)
- 4 BLISTER PACK in 1 CARTON (72205-239-64) / 28 CAPSULE in 1 BLISTER PACK
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "13b46e09-62d2-4ce9-b3c0-deafcb1f1842", "openfda": {"nui": ["N0000175605", "N0000020009", "N0000187062", "N0000182137", "N0000187064", "N0000187063", "N0000191272", "N0000185503"], "upc": ["0372205237926", "0372205239630", "0372205238640", "0372205239647"], "unii": ["F41401512X"], "rxcui": ["746606", "997653", "2002717"], "spl_set_id": ["13b46e09-62d2-4ce9-b3c0-deafcb1f1842"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "UGT1A1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 CAPSULE in 1 BLISTER PACK (72205-239-63)", "package_ndc": "72205-239-63", "marketing_start_date": "20251120"}, {"sample": false, "description": "4 BLISTER PACK in 1 CARTON (72205-239-64) / 28 CAPSULE in 1 BLISTER PACK", "package_ndc": "72205-239-64", "marketing_start_date": "20251120"}], "brand_name": "nilotinib", "product_id": "72205-239_13b46e09-62d2-4ce9-b3c0-deafcb1f1842", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "72205-239", "generic_name": "nilotinib", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "nilotinib", "active_ingredients": [{"name": "NILOTINIB", "strength": "200 mg/1"}], "application_number": "ANDA218544", "marketing_category": "ANDA", "marketing_start_date": "20251119", "listing_expiration_date": "20261231"}